Can Treating Gum Disease Lower Your Blood Sugar? What 35 Trials Found — and What a 0.4-Point A1c Drop Really Means
Last updated: 21 October 2026
Quick answer
In people with diabetes, a professional deep clean for gum disease is associated with a modest but clinically meaningful drop in HbA1c. The 2022 Cochrane review of 35 randomised trials (3,249 participants, almost all with type 2 diabetes) found an average reduction of 0.43 percentage points (4.7 mmol/mol) at 3–4 months and 0.30 points at 6 months compared with no treatment or usual care, and rated the evidence as moderate certainty. The reviewers called the effect clinically meaningful, but they also note that no trial measured diabetes complications, so we do not yet know whether the drop translates into fewer of them.
The practical takeaway is that gum care belongs in a diabetes plan alongside food, movement and medication — not instead of any of them. The professional cleaning is what the trials tested. A daily gum-line product such as Dental Pro 7, a water-free lipid concentrate, is one example of a cosmetic that supports the look of healthier, pinker gums between visits; it is not a diabetes or gum-disease product and does not replace dental care or blood-sugar management.
Why would your gums have anything to do with your blood sugar?
The link runs in both directions, which is why it is often described as a loop rather than a one-way street. The European Federation of Periodontology (EFP) states plainly: “There is a bidirectional (two-way) relationship between periodontitis and diabetes.” Diabetes “increases the risk of suffering periodontitis,” and periodontitis “is significantly associated with poorer glycaemic control (HbA1c).”
The US National Institute of Dental and Craniofacial Research (NIDCR, page last reviewed October 2024) explains the first half: “People with poor blood glucose control get gum disease more often and more severely,” and diabetes “may also cause the level of sugar (glucose) in your saliva to increase.” It adds that diabetes can slow recovery, which may get in the way of gum-disease care. Harvard School of Dental Medicine’s David Wu, writing in the Harvard Gazette (27 October 2025), describes persistently high blood sugar as weakening the immune system’s ability to fight infection and promoting chronic inflammation in the mouth, with higher saliva glucose helping oral bacteria multiply and plaque build up.
The second half — gum inflammation making blood sugar harder to manage — is the part the trials below try to test. Wu’s explanation: “Treating gum disease reduces chronic inflammation in the body, which can enhance the body’s response to insulin.” That is a plausible mechanism rather than a proven one, which is exactly why the trial data matter.
How common is the overlap?
Gum disease is common in everyone, and more so with diabetes. The Harvard Gazette piece reports that people with diabetes are about three times more likely to develop periodontal disease, and cites the World Health Organization estimate that about half of adults worldwide have gum disease. The CDC (page last reviewed 15 May 2024) calls gum disease “a leading cause of tooth loss” and reports that adults aged 50 and over with diabetes have fewer than 20 teeth 46% more often, and 8 or fewer teeth 56% more often, than adults without diabetes.
The older long-term evidence points the same way. A University of Michigan Record report from January 1999 on research presented by George W. Taylor described people with type 2 diabetes being about three times as likely as people without diabetes to develop periodontal disease in a long-running Pima Indian study, and people with more severe gum disease being “six times more likely to have poor glycemic control at follow-up.” That is a 1999 news report of a specific population, so treat it as historical context rather than a current estimate.
What the 35 trials actually found
The key source is the Cochrane review by Simpson TC, Clarkson JE, Worthington HV and colleagues, Treatment of periodontitis for glycaemic control in people with diabetes mellitus (Cochrane Database of Systematic Reviews, 2022, Issue 4, CD004714). It pooled randomised trials comparing periodontal treatment — mainly “subgingival instrumentation”, the professional deep clean below the gum line also called scaling and root planing — with no treatment or usual care. Some trials added antimicrobial rinses, gels or antibiotics, or hygiene instruction; surgery was rarely part of them.
The Cochrane numbers, translated
| Follow-up | Trials (participants analysed) | Average HbA1c reduction | 95% confidence interval | How much to trust it |
|---|---|---|---|---|
| 3–4 months | 30 (2,443) | 0.43 points (4.7 mmol/mol) | 0.28 to 0.59 points | Moderate certainty — the headline result |
| 6 months | 12 (1,457) | 0.30 points (3.3 mmol/mol) | 0.08 to 0.52 points | Results varied a lot between trials (I² = 80%) |
| 12 months | 1 (264) | 0.50 points (5.4 mmol/mol) | 0.45 to 0.55 points | A single trial — encouraging, not conclusive |
Source: Simpson et al., Cochrane Database Syst Rev 2022 (CD004714), as reported in the review’s abstract and plain-language summary and in a McMaster Optimal Aging summary. Confidence intervals are shown as reductions. The three-row layout and the “how much to trust it” column are our summary of the review’s own statements.
The review’s authors concluded that periodontal treatment improves glycaemic control by a clinically significant amount, and the plain-language summary describes the benefit as “probably” real, with moderate certainty. The CDC’s fact page takes the same line, stating that treating gum disease “significantly improves blood sugar level (glycemic control) among people with diabetes,” and the EFP FAQ says periodontal treatment in people with diabetes “results in a significant reduction in HbA1c levels,” measured about three months after therapy.
What a 0.43-point drop looks like in real life
A drop of 0.43 percentage points is easy to read past, so here is simple arithmetic (our illustration, not a prediction for any individual): an HbA1c of 8.0% (64 mmol/mol) falling by the average 0.43 points would land near 7.6% (about 59 mmol/mol). The review authors judged an effect of this size to be clinically meaningful. It is an average across trials, though — some participants will see more, some less, and the confidence intervals show the true average could plausibly sit anywhere between about 0.3 and 0.6 points at the 3–4 month mark.
The most useful way to think about it is as one more lever, not a replacement for the others. Nothing in the evidence suggests gum treatment lets anyone reduce or stop diabetes medication, and no one should change a prescribed regimen on the strength of this article. Decisions about medication belong with your doctor or diabetes team.
The limits — what the trials can’t tell you yet
The Cochrane summary is candid about its own gaps, and they are worth knowing before you build expectations:
| Open question | What the review says |
|---|---|
| Does it prevent diabetes complications? | Not known — no trial measured complications, and none reported costs |
| Does it work in type 1 diabetes? | Not known — almost all participants had type 2 (one trial included either type; none studied type 1 alone) |
| How long does the benefit last? | Follow-up was 3–12 months; only one trial reported at 12 months, so long-term effects are unclear |
| How reliable are the trials? | Of 35 studies, 2 were at low risk of bias, 14 at high risk and 19 unclear, mainly because people could not be blinded to treatment; a check using only the low-risk studies supported the main finding |
| Are there harms? | Most trials did not measure adverse effects; those that did generally reported none or only mild ones |
| Do antimicrobial add-ons help? | Not known — subgroup analyses were inconclusive |
Source: Cochrane plain-language summary and abstract, Simpson et al. 2022. The Endocrine-journal commentary summarised by McMaster Optimal Aging adds that the meta-analysis “still does not provide conclusive evidence,” while noting that good glycaemic control matters for both the development and the treatment of periodontitis in diabetes.
What gum treatment involves — and why “done once” isn’t the plan
The EFP’s clinical guideline for stage I–III periodontitis (Sanz et al., J Clin Periodontol 2020) lays out a stepped approach: behaviour change and plaque control come first, with diabetes control named as a necessary risk-factor step; then subgingival instrumentation, which “should be implemented in all periodontitis patients” and re-evaluated after healing time; with further steps only if deep, bleeding pockets remain. The American Academy of Periodontology adds that “the majority of patients will require ongoing maintenance therapy to sustain periodontal health.” StatPearls describes periodontitis as a chronic condition for which ongoing maintenance is critical.
That matters for blood sugar because the trials tested a treatment, and a long-lasting benefit would logically depend on keeping the gums calm afterwards. Harvard’s Wu suggests professional hygiene care at least twice a year, and notes people with diabetes may need maintenance visits about every three months. The EFP says that even without gum disease, people with diabetes “should still get regular dental check-ups as part of managing your diabetes.”
Warning signs worth acting on
NIDCR notes that people with diabetes sometimes notice gums that look swollen and bleed when they brush and floss, plus dryness, soreness, white patches or a bad taste — all reasons to see a dentist. Harvard adds persistent bad breath, tenderness, receding gums and loose teeth, and stresses that early signs are often painless. If bleeding does not settle within about two weeks of better cleaning, Cleveland Clinic advises booking a dentist. For more on specific signs, see early gum disease: signs and self-check, why do my gums bleed?, what causes loose teeth in adults and, because dry mouth is common with diabetes, why is my mouth always dry?
The diabetes-aware dental visit checklist
This is the information-gain piece: a practical checklist assembled from the NIDCR, EFP and Harvard advice quoted above. It is our synthesis for use at appointments, not a clinical protocol.
- Tell the dental team you have diabetes — and bring your latest HbA1c if you have it. NIDCR and EFP both advise telling your dentist about your diabetes and medication changes.
- Ask for a gum check, not just a “clean”. Ask whether your gums were measured (pocket depths) and whether any sites bled; the EFP guideline uses bleeding pockets as the trigger for further steps.
- If you have gum disease, ask what the plan is and when you will be re-checked. The guideline calls for re-evaluation after healing, and the AAP says most patients need ongoing maintenance.
- Agree a visit interval. Harvard’s suggestion is at least twice a year, with maintenance about every three months for some people with diabetes; your dentist will set what fits your gums.
- Note mouth changes between visits — bleeding that lasts beyond two weeks, white patches, soreness, dry mouth, a bad taste, a loose tooth — and report them promptly.
- Keep your diabetes team in the loop. The 3–4 month window in the trials is a sensible time to see whether your next HbA1c result moves, but any interpretation belongs with your doctor.
- Stop smoking if you smoke. NIDCR lists it as worsening gum disease, and the EFP guideline recommends cessation as part of the first step.
Daily gum care that fits around professional care
The EFP’s patient advice is deliberately simple: brush twice a day, clean between your teeth, and avoid smoking. NIDCR’s list is similar — keep blood glucose under control, brush twice daily, floss regularly, get routine dental checkups. For technique, see how to brush your teeth properly with gum disease. If you have just had a deep clean and your gums are still bleeding, this timeline explains what to expect. Two other posts cover factors that sit alongside blood sugar: can diet improve gum health? and can stress cause gum disease?
Where a gum-line lipid concentrate fits — and where it doesn’t
To be clear about the role: no cosmetic changes blood sugar, and none replaces the professional deep clean that the trials tested. Where a daily gum-line product fits is the ordinary job of keeping the gum line looking and feeling its best between dental visits, on top of brushing and interdental cleaning.
Dental Pro 7 is a 100% water-free botanical lipid concentrate built on a design principle we call Lipid-Lock: because it contains no water, it clings to the gum line and stays in contact for hours rather than being flushed away in seconds the way a water-based paste or rinse is. It blends eleven botanical lipids — immortelle helichrysum, pomegranate seed, black cumin seed, Indian myrrh, wild clove, white thyme and eucalyptus among the actives, a peppermint–spearmint–wild-mint freshness trinity, and a grapeseed, sunflower and vitamin E base — and supports the look of firmer, pinker, healthier-looking gums, with the look of redness reduced, and a mouth that looks and feels cleaner and fresher.
How to use it: four drops on a dry toothbrush in place of toothpaste, brush gently for about two minutes with the bristles angled into the gum line, then spit — do not rinse with water. Rinsing washes the lipid layer straight off and defeats the design. If your gums are sore, raw or bleeding, have your dentist look at them before adding anything new.
Because the formula is anhydrous it is preservative-free by design — no water, no fillers, no SLS or foaming agents, no fluoride, no parabens; vegan and non-GMO. It naturally contains eugenol, limonene and linalool from its botanicals, and it is made in a facility that handles nut oils. If you have diabetes and a dry or sore mouth, mention any new product to your dentist.
- Rating: Dental Pro 7 is rated 4.9 out of 5 from 293 reviews, with over 500,000 bottles sold.
- Guarantee: backed by a 90-day money-back guarantee.
- Formulated by S. C. Aris.
- What it is for: supporting the appearance of a cleaner, fresher mouth and healthier-looking gums. It is a cosmetic complement to brushing, interdental cleaning and professional dental care — not a substitute for any of them, and not a diabetes product.
Explore Dental Pro 7. Companion reading: why are my gums pale or white? and what causes loose teeth in adults.
Frequently asked questions
Can treating gum disease lower blood sugar? In people with diabetes, yes, on average. A 2022 Cochrane review of 35 randomised trials found HbA1c fell by about 0.43 percentage points (4.7 mmol/mol) at 3–4 months after professional periodontal treatment, compared with no treatment or usual care, with moderate-certainty evidence.
Does diabetes cause gum disease? It raises the risk. NIDCR says people with poor blood glucose control get gum disease more often and more severely, and Harvard’s David Wu reports people with diabetes are about three times more likely to develop it. Diabetes is a risk factor rather than the only cause — plaque and smoking matter too.
Does gum disease make diabetes worse? The EFP says periodontitis is significantly associated with poorer glycaemic control, and NIDCR says gum disease may make blood sugar harder to control. The relationship is described as two-way.
How long after a deep cleaning does blood sugar improve? In the Cochrane review the main effect was measured at 3–4 months, when the average reduction was 0.43 points. At 6 months the average was 0.30 points, and a single trial reported 0.50 points at 12 months.
Does this apply to type 1 diabetes? That is not known. Almost all trial participants had type 2 diabetes, and no trial studied type 1 alone.
How often should people with diabetes see a dentist? The EFP advises regular check-ups even without gum disease. Harvard’s Wu suggests professional hygiene care at least twice a year, with maintenance about every three months for some people with diabetes; your dentist will set the interval for you.
Can a gum product lower my A1c? No. A cosmetic gum-line product such as Dental Pro 7 supports the look of healthier, pinker gums. It does not change blood sugar and does not replace professional dental care or diabetes management.
The bottom line
The best current evidence says professional gum treatment is linked to an average HbA1c drop of about 0.3 to 0.5 points in people with diabetes, mostly type 2, measured over 3 to 12 months — moderate-certainty evidence that the Cochrane authors consider clinically meaningful. What is still unknown is whether it reduces complications, whether it works in type 1, and how long the effect lasts. Tell your dentist about your diabetes, ask for a gum check, agree a maintenance plan, and keep your diabetes team informed.
Sources: Simpson TC et al., Cochrane Database Syst Rev 2022 (CD004714) and McMaster Optimal Aging summary; EFP, “Perio & Diabetes FAQs”; NIDCR, “Diabetes and Your Mouth” (rev. Oct 2024); CDC, Diabetes and Oral Health fast facts (rev. 15 May 2024); Refior K, Harvard Gazette, 27 Oct 2025; Ross-Flanigan N, University of Michigan Record, 25 Jan 1999; Sanz M et al., J Clin Periodontol 2020 (EFP S3 guideline); American Academy of Periodontology, “Non-Surgical Treatments”; StatPearls, “Periodontal Disease” (upd. May 2025); Cleveland Clinic, “Bleeding Gums.”
This article is for general information and describes cosmetic products by appearance and feel; it is not medical or dental advice. Do not change any diabetes medication or treatment plan without speaking to your doctor. Bleeding gums that do not improve within two weeks, loose teeth, persistent bad breath or any painful or swollen area should be assessed by a dentist.